A carregar...
Effects of biological therapies on chronic rhinosinusitis in severe asthmatic patients
OBJECTIVE: The introduction of monoclonal antibody (mAb) therapies represents a promising treatment for refractory chronic rhinosinusitis (CRS). We assessed the effects of selected mAbs (omalizumab, mepolizumab, benralizumab) on CRS in severe asthmatic patients in a real-life setting. METHODS: A pro...
Na minha lista:
| Publicado no: | Acta Otorhinolaryngol Ital |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Pacini Editore Srl
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7889250/ https://ncbi.nlm.nih.gov/pubmed/33558772 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14639/0392-100X-N0716 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|